BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for ELI LILLY AND COMPANY, FORMERLY REPORTED AS, LILLY USA, LLC · Pharmaceuticals

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Indiana · House · Senate · $90,000.00 income · posted Jan 16, 2026

Lobbying activity 2

Pharmacy

Issues related to the pharmaceutical industry Issues related to Inflation Reduction Act Implementation Treat and Reduce Obesity Act Pharmaceutical tariffs Safe Drugs Act

Health Issues

Issues related to biotechnology legislation Diagnostic tests Clinical trial issues Issues related to supply chain

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.